Multinational companies active in conducting domestic clinical trials

It was observed multinational companies have actively conducted domestic clinical trials to develop new drugs.

According to the clinical trial approval report of the Ministry of Food and Drug Safety, 6 multinational companies were approved to conduct clinical trials since the last 1^st of December.

First of all, Lilly Korea unveiled ramucirumab + MEDI4736 for ‘locally advanced and unresectable...